Covaxin maker Bharat Biotech’s Joint Managing Director Suchitra Ella made a tweet concerning about employees.

She tweeted ‘50 of their employees have tested COVID positive has evoked a mixed response from netizens with some questioning the effectiveness of its anti-COVID vaccine and while others wondering why the staff members were not vaccinated.’ Some political leaders commenting over COVID-19 vaccine Covaxin supply issues, Ella had replied with a tweet “Quite disheartening to the teams to hear some states complaining about our intentions. 50 of our employees are off work due to Covid, yet we continue to work under pandemic lockdowns 24x7 for U.” Ella’s tweet got 9373 likes and was retweeted by 2564. She also added in her statement that as many as 18 states received Covaxin though in smaller shipments. Meanwhile, the Drugs Controller General of India has given its approval to Bharat Biotech to start conducting Phase two and three clinical trials of its COVID-19 vaccine Covaxin on children above 2 years old.

The national drug regulator said that it has accepted the recommendation of the SEC “after careful examination” and accorded permission to Covaxin manufacturer Bharat Biotech.

Also Read

Startups: Techstars Bangalore picks 9 startups for third cohort in India

If you don’t accept new privacy policy WhatsApp calls, other features stops working after May 15

Big news! RSS constructed 30 beds hospital in Bareilly